The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of immune architecture on response to adjuvant capecitabine in triple-negative breast cancer (FinXX trial).
 
Saranya Chumsri
Consulting or Advisory Role - Syndax
Research Funding - Merck
 
Karama Asleh
No Relationships to Disclose
 
Heather Ann Brauer
Employment - NanoString Technologies
Travel, Accommodations, Expenses - NanoString Technologies
 
Douglas Hinerfeld
Employment - NanoString Technologies
Travel, Accommodations, Expenses - NanoString Technologies
 
Jennifer M. Kachergus
No Relationships to Disclose
 
Susanna Lauttia
No Relationships to Disclose
 
Henrik Lindman
No Relationships to Disclose
 
Torsten Nielsen
Stock and Other Ownership Interests - Bioclassifier
Consulting or Advisory Role - NanoString Technologies
Patents, Royalties, Other Intellectual Property - PAM50 Breast Cancer Classifier
 
Heikki Joensuu
Employment - Neutron Therapeutics; Orion
Leadership - Sartar Therapeutics
Stock and Other Ownership Interests - Faron Pharmaceuticals; Orion
Consulting or Advisory Role - Neutron Therapeutics
Patents, Royalties, Other Intellectual Property - Sartar Therapeutics
 
E. Aubrey Thompson
No Relationships to Disclose